CURRICULUM VITAE (Fall, 2009) Donald R. Bodner, M.D. Professor of Urology Case Western Reserve University Cleveland, Ohio Attending Physician University Hospitals/ Case Medical Center Staff Urologist Cleveland VA Medical Center Cleveland, Ohio Email: [email protected] Academic focus: neuro-urology, spinal cord medicine, stone disease APPOINTMENTS Interim Chair, Department of Urology, CWRU School of Medicine and UH Case Medical Center, 5/1/07-7/31/09 Program Director: CWRU Urology Residency Program 5/1/07-7/31/08 Editor in Chief: Journal of Spinal Cord Medicine: 1/01/2006 to present Urology Section Editor, Journal of Spinal Cord Medicine: 1992- 2006 Editorial Board: International Journal of Impotence Research, 2005-present VA National Urology Field Advisory Committee, 2001-March 1, 2009 Chair 2004 –March 1, 2009. VA National Surgery Advisory Board, Urology Chair, March 1, 2009 to present Member: International Spinal Cord Injury Standards and Data Sets Committee, a joint effort of the American Spinal Injury Association (ASIA) and the International Spinal Cord Society (ISCoS) 2006- 2009 Reviewer: National VA Merit Review Committee, Rehabilitation Research and Development, 2000 –present Reviewer: Congressionally Directed Medical Research Programs (CDMRP), 2009 Panel Member: Paralyzed Veterans of America: The Consortium for Spinal Cord Medicine 2003-2006 American Paraplegia Society: Board of Directors 2006-present; Program Committee 2006-2009 American Paraplegia Society Netwellness: www.netwellness.org Urology Advisor Consultant/Member Oncology Advisory Group to the Department of Veterans Affairs Program Evaluation Oversight Committee – 2004-2008 CURRENT GRANTS Electrical Activation of Afferent Nerves to Restore Bladder Function Co-Investigator: Donald Bodner 5% Department of Veterans Affairs RR&D B3675R (PI Kenneth J. Gustafson) Production of micturition and continence via peripheral afferent stimulation. Type: Period: 4/1/06-3/31/09 Producing Micturition by combined afferent and efferent stimulation Co-Investigator: Donald Bodner 5% National Institute of Diabetes and Digestive and Kidney Disease R01 DK077089-01A1 (PI: Kenneth J. Gustafson, PhD) Project Period: 09/01/2007-06/30/2011 Budget Period:: 9/1/2007-6/30/2008: $253,380 Selenium and Vitamin E Cancer Prevention Trial SELECT Principal Investigator: Donald Bodner Funding Agency: (SWOG) Type: Period: 2001-present. Study Site: Cleveland VA Medical Center Botulinum Toxin A for management of spinal cord injury incontinence Principal Investigator: Donald Bodner Funding agency: Allergan Type: Period: 2007-present. Study Site: Cleveland VA Medical Center Current Medical School Service: Master Thesis Committee Advisor, Dr Hohete Case Western Reserve School of Dentistry 7/1/07-6/30/08. “Periodontal Inflammation and Prostatitis -Is there an association? Master Thesis Committee Advisor: Josh Nishant, DDS: 7/1/08-6/30/09 “Relationship between the Periodontal Inflammation and Elevated Prostate-Specific Antigen (PSA) Levels in Patients with Prostatic Inflammation” PERSONAL DATA Date of Birth: Office Address: Office Phone: Alternate Contact: August 31, 1953 University Hospitals/ Case Medical Center Department of Urology 11100 Euclid Avenue Cleveland, Ohio 44106 (216) 844-5503 Dept. of Veterans Affairs Medical Center Spinal Cord Injury Service 128W 10701 East Boulevard Cleveland, Ohio 44106 Phone: (216) 791-3800, ext. 3062 MetroHealth Medical Center Division of Urology 2500 MetroHealth Drive Cleveland, Ohio 44109 EDUCATION 1975 - B.S. Trinity College Hartford, Connecticut 1979 - M.D. Indiana University School of Medicine Indianapolis, Indiana 1979 – 1980 Intern, Surgery Case Western Reserve University Cleveland, Ohio 1980 – 1981 Resident, Surgery Case Western Reserve University Cleveland, Ohio 1981 - 1983 Resident, Urology Case Western Reserve University Cleveland, Ohio 1983 – 1984 Chief Resident, Urology Case Western Reserve University Cleveland, Ohio LICENSURE FLEX May 1979 Indiana #29413 August 14, 1979 Ohio #044291 November 20, 1979 SPECIALTY CERTIFICATION Board Certified; The American Board of Urology, 1986; Recertified; 1994, 2004 Fellow, American College of Surgeons, 1987 MEDICAL SCHOOL AFFILIATION 7-1-84 to 12-31-84 Senior Instructor, Division of Urology Department of Surgery, Case Western Reserve University School of Medicine 1-1-85 to 6-30-92 Assistant Professor, Division of Urology Department of Surgery, Case Western Reserve University School of Medicine 7-1-92 to 6-30-99 Associate Professor, Dept. of Urology, Case Western Reserve University School of Medicine 7-1-99 to present Professor of Urology, Dept. of Urology Case Western Reserve University School of Medicine 5-1-07 to 7/31/09 Professor and Interim Chair, Department of Urology, UH Case Medical Center and Case Western Reserve University School of Medicine PROFESSIONAL ORGANIZATIONS: American Spinal Injury Association (ASIA) Urology Committee 1993-1995; 1995-1997, 1998- 2000 International Spinal Cord Society (ISCOS, Formerly International Medical Society of Paraplegia) North Central Section, American Urological Association American Urologic Association Society of University Urologists Executive Committee VA Liaison, 2000-2005 Executive Committee Member-Councilman, 2000-2005 Subcommittee on Urology in the V.A. (1995-1998) Nominating Committee 2003-2004 American Paraplegia Society Board of Directors, 1988-1996, 2006- (ex-officio because of Editor of Journal of Spinal Cord Medicine) Nominating Committee Member - 1989-90; 1993-1996 Chairman - 1991-1992; 1995-1996; 1996-1997 Education Committee, 1993-1995 Long Range Planning Committee, 1995-2004 Secretary, Treasurer, 1989-1991 Vice President, 1991-1993 President, 1993-1995 Past President, 1995-1997 Program Committee 2002-2006, reappointed 2006-2009 Cleveland Urological Society Secretary, Treasurer - 1990-1992 President - 1992-1993 Society for Urodynamics and Female Urology International Continence Society Societe Internationale D'Urologie Cleveland Academy of Medicine Ohio State Medical Association PREVIOUS RESEARCH GRANTS Consultant: “Career Training in Bladder Control Neural Prothesis” 2001-2004 NIH Grant No. HD40298-02 Effect of Sildenafil (Viagra) in Spinal Cord Injured Men. Co-Principal Investigator: Donald Bodner Agency: Pfizer. Type: Period: 1998 – 2002; $75,000 Co-Principal Investigator: “Electrical Control of Bowel and Bladder in Spinal Cord Injury Patients” VA Central Office, Rehab, Research and Development Service Grant NO. B804-2R 1998-1999 $300,000 1999-2000 $241,000 2000-2001 $200,200 Co-Principal Investigator: “Neuroprosthetic Control of Bladder and Bowel in Spinal Injury Patients” VA Central Office, Rehab. Research and Development Service Grant NO. B804-RC 1994-1995 $193,700 1995-1996 $141,100 1996-1997 $120,200 Co-Investigator: “Bowel and Bladder Control Using Neuroprosthetic Devices” HD/NR-93-05 1993-1995 $178,000 Co-Principal Investigator: “Neuroprosthetic Control of Bladder and Bowel in Spinal Injury Patients” VA Central Office, Rehab. Research and Development Service Pilot Grant NO. B91-299 PA 10-92 to 10-93 $ 50,000 Co-Investigator: “A Micturition Assist Device” NIH - NINCDS Grant NO. NS22631-02 1987-1988 $ 78,297 1988-1989 $ 62,233 1989-1990 $ 72,970 1990-1992 $ 98,510 INDUSTRY FUNDED STUDIES 1. A double-bind, placebo-controlled, multi-center study to determine the safety and efficacy of Didronel in the treatment of painful bone metastasis from hormone resistant prostate cancer, NORWICH EATON PHARMACEUTICALS INC., 1986. (Co-Investigator). 2. Multi-center comparison of Zoladex Depot and Surgical Castration in Metastatic Prostate Carcinoma, STUART PHARMACEUTICALS, 1985-1988. (Co-Investigator). 3. A multi-center comparison of Zoladex Depot and DES for patients with metastatic prostate cancer who have refused orchiectomy, STUART PHARMACEUTICALS, 19851988. (Co-Investigator). 4. A double-bind comparative, safety, tolerance and efficacy study of parenteral Piperacillin - Tazobactam (CL 298, 741) versus Ceftazidime for the treatment of hospitalized patients with complicated UTIs. Phase III Multi-center Study. American Cyanamid Co., 1988-1990. (Co-Investigator). 5. A study of Cefepime in the treatment of serious bacterial infections particularly those caused by staphylococci, pseudomonas and other less common GRAM-NEGATIVE BACILLI. Bristol-Myers Company, 1990-1991. (Co-Investigator). 6. A phase II dose finding placebo controlled study of four dose levels of YM 617 in patients with the signs and symptoms of benign prostatic hyperplasia. Yamanouchi Pharmaceutical Company, Ltd., 1990. (Principal Investigator). 7. A double-bind, placebo controlled, multi-center study to investigate the safety, tolerability, and efficacy of MK-906 in patients with benign prostatic hyperplasia. MERCK, SHARP & DOHME, 1988. (Co-Investigator). 8. A double-bind, placebo-controlled, multi-center study to investigate the safety, tolerability and efficacy of MK-906 in patients with benign prostatic hyperplasia, MERCK SHARP & DOHME, 1989-1990. (Co-Investigator). 9. A double-bind, placebo-controlled, multi-center extension study to investigate the safety, tolerability and efficacy of MK-906 in patients with benign prostatic hyperplasia, 19891990. (Co-Investigator). 10. An open extension to the multi-center, double-bind extension study to investigate the safety, tolerability, and efficacy of MK-906 in patients with benign prostatic hyperplasia. MERCK, SHARP & DOHME, 1989-1991. (Co-Investigator). 11. Ultrasound Prostate Cancer Network, characteristics of adenocarcinoma and accuracy of ultrasound compared to digital rectal exam in staging, 1989. (Co-Investigator). 12. Ultrasound Prostate Cancer Network, transrectal ultrasound of prostate prior to transurethral resection of prostate for benign prostatic hyperplasia, 1989. (CoInvestigator). INDUSTRY FUNDED STUDIES (continued) 13. Ultrasound Prostate Cancer Network, transrectal prostate ultrasound prior to cystoprostatectomy for treatment of cancer of the bladder, 1989. (Co-Investigator). 14. A double-blind randomization Placebo Controlled Dose Ranging Study of Atamestane to Evaluate the Efficacy, Safety and Endocrinological Effects in Patients with benign prostatic hyperplasia. BERLEX LABORATORIES, 1991. (Co-Investigator). 15. Extended (up to 18 months) double-blind evaluation of Atamestane and placebo study to the long-term efficacy, safety and endocrinological effects in patients with benign prostatic hyperplasia. BERLEX LABORATORIES, 1991. (Co-Investigator). 16. Third open extension to the multi-center, double-blind extension study to investigate the safety, tolerability, and efficacy of Finasteride in patients with benign prostatic hyperplasia. MERCK SHARP & DOHME, 1991. (Co-Investigator). 17. An open-label extension study using Doxazosin tablets for the treatment of benign prostatic hyperplasia in Normotensive patients. PFIZER PHARMACEUTICALS, 1991. (Co-Investigator). 18. A fourteen-week, double-blind, placebo controlled dose response study using Doxazosin tablets for the treatment of benign prostatic hyperplasia in normotensive patients. PFIZER PHARMACEUTICALS, 1991. (Co-Investigator). 19. The effect of fourteen days treatment with SK & F 105657 on prostatic and serum DHT levels in patients with benign prostatic hyperplasia scheduled for transurethral resection of the prostate. SMITH KLINE BEECHAM PHARMACEUTICALS, 1991. (CoInvestigator). 20. Clinical trials of safety and effectiveness of the prostate treatment machine (PTM) for transrectal thermal therapy of patients with benign prostatic hyperplasia. PRIMUS TECHNOLOGIES INC., 1991. (Co-Investigator). 21. Clinical trials of the safety and effectiveness of the prostate treatment machine (PTM) for transrectal thermal therapy of patients with benign prostatic hyperplasia using temperature sensoring. PRIMUS TECHNOLOGIES, INC., 1991. (Co-Investigator). 22. Clinical trials of the safety and effectiveness of the prostate treatment machine (PTM) for transrectal thermal therapy of patients with benign prostatic hyperplasia the control group. PRIMUS TECHNOLOGIES, INC., 1991. (Co-Investigator). 23. A monitored release of named patient basis study for Zoladex Depot in metastatic prostate carcinoma. ICI PHARMACEUTICALS, 1991. (Co-Investigator). 24. A randomized controlled comparison of Deslorelin to Leuprolide for the treatment of stage D2 prostate cancer. ROBERTS PHARMACEUTICAL CORP., 1992. (Principal Investigator). INDUSTRY FUNDED STUDIES (continued) 25. 26. A one-year, multi-center, double-blind comparison of the effects of once-daily dosing with three dose levels of SK & F 105657 or placebo in the treatment of symptomatic benign prostatic hyperplasia with six-month untreated follow-up. SMITH KLINE BEECHAM PHARMACEUTICALS, 1992. (Principal Investigator). Multi-center Efficacy and Tolerability Study Comparing Proscar (Finasteride) and placebo in the Treatment of Symptomatic Benign Prostatic Hyperplasia, MERCK, 1993. (Principal Investigator). 27. A two-year, open-label, multi-center study of oral Episteride 80 mg. once daily in the treatment of benign prostatic hyperplasia (SK&F 105657/052). SMITH KLINE BEECHAM PHARMACEUTICALS, 1993 – 1996. (Principal Investigator). 28. A Three Month, Double-Blind, Placebo-Controlled, Randomized, Multi-center Study of the Effects and Safety of SB 21649-S In Patients with Symptomatic Benign Prostatic Hyperplasia, Smith Kline Beecham, King of Prussia, PA, 1995. (Principal Investigator). 29. A Four Year Open Label Multicenter Study of Oral Epristeride 80 mg Once Daily in the Treatment of BPH, Smith Kline Beecham, King of Prussia, PA; January, 1996 to August, 1996. (Principal Investigator). 30. A Pharmacology Based Efficacy. Trial of Intravesical Mytamycin C in Bladder Cancer and Interactive Pharmacology Studies (05-94-29). Ohio State University, Columbus, Ohio; September, 1994 to 1997. (Co-Investigator). 31. Long-Term Safety Study for Alprostadil Sterile Powder (PGE, Alprostadil S. Po.) in Patients with Erectile Dysfunction. Pharmacia and Upjohn, Inc., Kalamazoo, Michigan, July 1992 to June 1994. (Co-Investigator). 32. Treatment of Erectile Failure by Means of a Medicated Urethral System for Erection (MUSE). Vivus Company, Menlo Park, California, June 1993 to July 1995. (CoInvestigator). 33. One-Year, Open-Label Evaluation of the Safety and Efficacy of Alprostadil Administered by MUSE. Vivus Company, Menlo Park, California, June 1994 to July 1995. (CoInvestigator). 34. A Placebo-Controlled Safety and Efficacy Study of Alprostadil Alphadex (PGE,-AlphaCyclodextrin) in the Treatment of Erectile Dysfunction followed by 48 weeks of OpenLabel Treatment. Corning Besselaar, Nashville, Tennessee, January 1993 to February 1996. (Co-Investigator). 35. An Open-Label Study of Intracavernous Injections of Alprostadil Aphadex for use in the Diagnosis of Erectile Dysfunction by Doppler Ultrasound. Schuarz Pharma, Milwaukee, Wisconsin, November 1994 to July 1995. (Co-Investigator). INDUSTRY FUNDED STUDIES (continued) 36. A Multicenter Phase 111B Open Label Study of Intracavernous Injections of Alprostadil Alphadex in the Treatment of Erectile Dysfunction in Patients with Insulin Dependent Diabetes Mellitus, Schuarz Pharma-CioClin, Austin, Texas, March 1996 to January 1998. (Co-Investigator). 37. A Treatment IND Protocol for the Compassionate Use of Elmiron for Patients with Recurring Symptoms of Interstitial Cystitis. Baker, Norton Pharmaceuticals, Inc., Miami, Florida; March, 1994 to 1997. (Principal Investigator). 38. A Randomized Double-Blind study with open label treatment extension to evaluate the efficacy and safety of Viagra (sildenafil) in men with symptoms of depression and erectile dysfunction PPD Pharmaco. Wilmington, North Carolina, September 1997 to November 1998. (Co-Investigator) 39. Two year open extension to a Double- Blind Randomized Placebo controlled multicenter study to investigate the long term effects of finasteride (MK-906) in patients with BPH. Merck. Princeton, New Jersey, January 1997 to November 1998. (CoInvestigator). 40. Efficacy and safety of Alfuzosin once daily tablets at two dose levels (10mg and 15mg) vs placebo in patients with symptomatic BPH: A Placebo - Controlled Double Blind study conducted in 3 parallel groups for 3 months followed by a nine month open label extension PPD Pharmaco. Wilmington, North Carolina. Jan 1998 to 2002 (CoInvestigator). 41. A Phase III Efficacy and Safety Study of Four Fixed Doses of Apomophoine SL Tablets vs Placebo in the Treatment of Male Erectile Dysfunction IBRD - TAP Pharmaceuticals Irvine, California August 1997 to August 1998. (Co-Investigator). 42. A Double-Blind Randomized, Placebo-Controlled Two Center Three Way Crossover Safety and Efficacy Study of Paroxetine Hydrochloride Capsules for the Treatment of Premature Ejaculation. Pentech Pharmaceuticals, Wheeling Illinois, May 1997 to January 1999. (Co-Investigator). 43. A Multicenter Open-Label Dose Escalation Study of the Safety and Therapeutic Effects of PPi-149 Depot Administration as an Intramuscular IM or Subcutaneous SC Injection in Prostate Cancer Patients who are Candidates for Initial Hormonal Therapy. Praecis Pharmaceuticals. Manisville, North Carolina. October 1997 to present. (Co-Investigator). 44. A phase III Long-Term, Open-Label, Flexible Dose Efficacy and Safety Study of Apomorphine SL Tab in the Treatment of Male Erectile Dysfunction IBRD - Tap Pharmaceuticals . Irvine, California. January 1998 to present. (Co-Investigator). 45. Dose Escalation Study with Tolterodine in Patients with Overactive Bladder. A single Blind Study in Patients with Symptoms of Overactive Bladder including Urinary Urgency and Frequency with or without Urge Incontinence. Pharmacia & UpJohn. Kalamazoo, Michigan. December, 1997 to August 1998. (Principle Investigator). INDUSTRY FUNDED STUDIES (continued) 46. A Pilot Evaluation of the Safety and Efficacy Dose response of Topical Gel Formulation of Prostaglandin El for the Treatment of Male Erectile Dysfunction. MacroChem. Lexington, Mass. March 1998 to November 1998. (Co-Investigator). 47. A phase III multicenter open label randomized study of abareliy depot vs. Lupron Depo plus Cabodex in patients with prostate cancer who are candidates for initial hormone therapy. Praecis. Cambridge, MA. Sept 1998 - present. (Sub-Investigator). 48. Clinical investigation of high intensity focused ultrasound (HIFU) for the treatment of Benign Prostatic Hyperplasia, (BPH). Focus Surgery. Indianapolis, IN. February 1999 – 2001. (Sub-Investigator). 49. Effect of Sildenafil (Viagra) in Spinal Cord Injured Men. Pfizer. 1998 - 2002. (Co-Investigator). 50. Longterm follow-up Sildenafil (Viagra) Therapy in Erectile Dysfunction. Departmental. April 2001 – Ongoing. (Co-Investigator). 51. Questionnare Assessment of Erectile Function Treatment and Outcome. Departmental. August 1998-Ongoing (Co-Investigator). 52. Molecular Diagnosis of Erectile Dysfunction. Departmental. July 1998-Ongoing. (CoInvestigator). 53. A Randomized, Double-Blind, Paralled Placebo Controlled Study of the Efficacy and Safety of IC351 Administered “On-Demand” to Men Erectile Dysfunction. Bayer Pharmaceuticals. December 2001-August 2002. (Co-Investigator). 54. Platelet Cyclic GMP Levels as a Surrogate Marker for Penile Cyclic GMP Levels: Platelets as a Surrogate Marker for Male Erectile Function. Departmental. December 2001-Ongoing. (Co-Investigator). 55. Peyronie’s Disease Questionnaire for Men with Prostate Cancer. Departmental. September 2001-Ongoing. (Co-Investigator) 56. A Clinical Assessment of Patients Undergoing GYNECARE TVT with Abdominal Guides for the Treatment of Stress Urinary Incontinence (Protocol 2001-012). GYCECARE. February 2002-Ongoing. (Co-Investigator) 57. Quality of Life Changes after Anti-Incontinence Surgery. Departmental. September 1991-Ongoing. (Co-Investigator) 58. A Randomized, Double-Blinded Study Comparing Chondrogel (Autologous Chondrocytes in Alginate Hydrogel for the Treatment of Women with Stress Urinary Incontinence due to ISD. Curis. April 2000-Dec. 2001. (Co-Investigator) INDUSTRY FUNDED STUDIES (continued) 59. The Clinical Study of the Treatment of Organ Confined Prostate Cancer using the Sonablate High Intensity Focus Ultrasound (Hufi). Focus Surgery. June 2001-Ongoing. (Co-Investigator) 60. Sexual Dysfunction in Men with Prostate Cancer who have undergone either Radiation or have had Radical Surgery. Departmental. June 2000-Ongoing. (Co-Investigator) 61. A Phase III Trial of Selenium for Prostate Cancer Prevention. Arizona Cancer Center. August 2000-Ongoing. (Principal Investigator) 62. Erectile Dysfunction Questionnaire on Men with Renal Disease. Departmental. March 2000-Ongoing. (Co-Investigator) 63. Predicting Fertility after Varicocelectomy. Departmental. November 2001-Ongoing. (CoInvestigator) 64. Does Chronic Sildenafile Use Improve Non-Sildenafil Erections. Pfizer. December 1999-Ongoing. (Co-Investigator) 65. A Randomized Double-Blind, Parallel Group, Placebo-Controlled Investigation Evaluating the Efficacy and Safety of Vardenafil Administered for 12 weeks in a FlexibleDose Regimen Compared to Placebo in Patients with Male Erectile Dysfunction Solely Secondary to Traumatic Spinal Cord Injury. 2002-2005. (Principal Investigator) 66. Prospective, Observational Registry and Patient Survey of the Management of Men with Symptomatic Benign Prostatic Hyperplasia (BPH), SANOFI AVENTIS, 2004-2007. (Principal Investigator) 67. A Prospective, Open-Label, Study To Assess The Efficacy Of Alfuzosin 10 MG Tablet Once A Day In Male Subjects Suffering From benign Prostate Hypertrophy Associated With Lower Urinary Tract Symptoms And Erectile Dysfunction, SANOFI AVENTIS, 20052008 (Co-Investigator) 68. A Prospective, Double-Blind Study to Determine the Safety and Efficacy of Botulinum Toxin A for the treatment of Neurogenic Urinary Incontinence (Principal Investigator-Site: VA) AWARDS 1. Certificate of Appreciation Paralyzed Veterans of America September 26, 1986 2. American Paraplegia Society Selected Paper Autoinjection for Erection March, 1987 3. Best Urology Paper of APIS Meeting Prize included funding for presentation at 18th Annual Meeting American Spinal Injury Association. March 19 - 22, 1987, Boston, Mass. 4. Second runner-up, Travelling Fellowship Essay Contest, 62nd Annual Meeting, North Central Section, American Urological Association Meeting,Orlando, Florida, November 13-19, 1988 "Urologic Changes After Spinal Cord Compression in Dogs". 5. Russell Hibbs Award for the most outstanding Basic Science Research Paper presented at the European Spinal Deformity Society and Scoliosis Research Society Meeting in Amsterdam, Holland, September 22, 1989: "UROLOGIC FUNCTION FOLLOWING EXPERIMENTAL CAUDA EQUINA COMPRESSION: CYSTOMETROGRAMS vs. CORTICAL EVOKED POTENTIALS." 6. First Place Ribbon for Best Urology Poster: Intraurethral MUSE for Treatment of Erectile Dysfunction in SCI Patients; 24th Annual Meeting American Spinal Injury Association, April 20 - 22, 1998, Cleveland, Ohio 7. 2007 Recipient- A. Eston Comarr, MD, Memorial Award for Clinical Service, American Paraplegia Society, “given to an APS member who has demonstrated exceptional accomplishments in the area of clinical care of persons with spinal cord injury, has had a significant impact on the field of spinal cord medicine and is recognized as a leading authority in the field of spinal cord health care and education.” NATIONAL, HOSPITAL AND MEDICAL SCHOOL COMMITTEES 1. Infection Control Cleveland Veterans Administration Medical Center, 1986-1992 2. Institutional Review Board Cleveland Veterans Administration Medical Center, 19881998 3. Credentialing Committee for Department of Surgery University Hospitals of Cleveland, 1987-1992, *Chairman, Credentialing Committee, 1990-1992 4. Credentialing Committee for Department of Urology , University Hospitals of Cleveland Chairman, 1992-1994, 2005-2006 5. NIDRR National Rehabilitation Engineering Center for Functional Electrical Stimulation (FES-REC), 1988-Present 6. Equipment Committee University Hospitals of Cleveland, 1989 7. Medical Director, Hospital Based Home Care, Spinal Cord Injury Service Cleveland Veterans Administration Medical Center, 1989-1998 8. Coordination of basic science lectures, pathology lectures, and Journal Club for urology residency - Division of Urology CWRU School of Medicine, 1985-1996 9. Institutional Review Board for Human Investigator Department of Urology (University Hospitals), 1992-2009 10. Medical Advisory Committee for the selection of the Patient Care Operations Support System, University Hospitals of Cleveland, 1992-1995 11. Faculty Council, Case Western Reserve University School of Medicine 1995-1999 Steering Committee 1996-1999 Chair Elect 1996-1997 Chair 1997-1998 Past Chair 1998-1999 12. Faculty Senate, Case Western Reserve University School of Medicine 2001-2004 Budget Committee 2002-2003 GUEST EDITORSHIPS Urologic Clinics of North America, Guest Editor, Spinal Cord Injury Edition, August, 1993. JOURNAL REVIEWER Journal of Spinal Cord Medicine (formerly Journal of American Paraplegia Society) Editor-in Chief (1/2006 to present) Journal of Urology Spinal Cord (formerly named Paraplegia) European Urology International Journal of Impotence Research Editorial Board (2005-present) Journal Rehabilitation Research Development GRANT REVIEWER Spinal Cord Research Foundation (SCRF) American Paraplegia Society NIDRR Study Section, 2001 VA Merit Review Rehab Research and Development 2000 - present PANEL MEMBER Guidelines for Primary Medical Management of Urinary Obstruction from Benign Prostatic Hyperplasia to the Dept. Of Veteran Affairs (finalizing guidelines and performance measures 1996-1999). Topic Expert to provide clinical/technical review of the clinical practice on MS bladder dysfunction for the Multiple Sclerosis Council and the Bladder Management guideline development panel (1998). Guidelines for Primary Care Management of Urinary Incontinence to Department of Veteran Affairs (2002-2003). Consortium of Spinal Cord Injury Guideline Panel. Clinical Practice Guideline for Bladder Management in the SCI Adult for Health Care Professionals, 2003-2006 (published 2006). PRESENTATIONS 1. 56th Annual Meeting, North Central Section, American Urological Association, Palliative Nephrostomy for Relief of Ureteral Obstruction Secondary to Pelvic Malignancy, Marco Island, Florida, October 17-23, 1982. 2. Annual Resident Presentations, Urologic Complications in Pregnancy, Cleveland Urologic Association, May, 1984. 3. 58th Annual Meeting, North Central Section, American Urological Association, Infundibular Stenosis, Cedar Rapids, Iowa, September 19-22, 1984 4. 58th Annual Meeting, North Central Section, American Urological Association, Primary Transitional Cell Carcinoma of the Prostate, Cedar Rapids, Iowa, September 19-22, 1984. 5. Case Western Reserve University School of Medicine, Postgraduate Medical Education Seminar, Entitled "Urology for the Non-urologist", Prostatitis and Urethritis, Cleveland, Ohio, October 27, 1984. 6. 80th Annual Meeting, American Urological Association, Infundibular stenosis, Atlanta, Georgia, May 12-16, 1985. 7. 31st Annual Meeting, American Paraplegia Society, Long-term Outcome of Ileal Loops in Spinal Cord Injured Patients, Las Vegas, Nevada, September 4-6, 1985. 8. 59th Annual Meeting, North Central Section, American Urological Association, Urologic Management of the Quadriplegic Female, Palm Beach, Florida, November 3-9, 1985. 9. 59th Annual Meeting, North Central Section, American Urological Association, LongTerm Outcome of Ileal Conduit in Spinal Cord Injured Patients, Palm Beach, Florida, November 3-9, 1985. 10. 59th Annual Meeting, North Central Section, American Urological Association, Ruptured Penis, Palm Beach, Florida, November 3-9, 1985. 11. Case Western Reserve University School of Medicine, "Urology for the Non-urologist", Benign Prostatic Hyperplasia, Cleveland, Ohio, November 23, 1985. 12. Case Western Reserve University School of Medicine, Postgraduate Course Entitled: "Impotency": a) Course Director; b) Talk Entitled: "Self-Injection for Impotence", An update (April 19, 1986). 13. 81st Annual Meeting, American Urological Association, AMS Sponsored Round Table Discussion. "Papaverine and Impotence". Invited Faculty: Bodner, Virag, Fishman, Furlow, Goldstein, Waggner, Sidi, New York, New York, May 19-23, 1986, 14. 32nd Annual Meeting, American Paraplegia Society, Autoinjection for Erection in the Spinal Cord Injured Male, Las Vegas, Nevada, September 3-5, 1986. PRESENTATIONS (continued) 15. Case Western Reserve University School of Medicine, Postgraduate Course Entitled: "Urology for the Non-urologist", October 25, 1986, 1) Prostatitis and Urethritis; 2) Impotency. 16. 60th Annual Meeting, North Central Section, American Urological Association, Injection of Vasoactive Medications in the Spinal Cord Injured Male, Palm Springs, California, November 9-16, 1986. 17. 60th Annual Meeting, North Central Section, American Urological Association, Fine Needle Aspiration Biopsy of the Prostate in Detecting Cancer, Palm Springs, California, November 9-16, 1986. 18. 60th Annual Meeting, North Central Section, American Urological Association, Ligation of the Bladder Neck as Alternative to Supravesical Diversion, Palm Springs, California, November 9-16, 1986. 19. 18th Annual Meeting, American Spinal Injury Association, (American Paraplegia Society Selected Paper) Autoinjection in Spinal Cord Injured Male, Boston, MA, March 19-22, 1987. 20. Case Western Reserve University School of Medicine, Postgraduate Course Entitled: Update in Urologic Oncology, Diagnosis and Management of Localized Renal Cell Carcinoma, April 24, 1987. 21. Annual Meeting of International Medical Society of Paraplegia, Role of Vasoactive Medication in SCI Potency, Aylesbury, England, May 13-15, 1987. 22. 61st Annual Meeting, North Central Section, American Urological Association, Adenocarcinoma in the Residual Bladder after urinary diversion for neurogenic bladder, Detroit, Michigan, September 16-19, 1987. 23. 61st Annual Meeting, North Central Section, American Urological Association, Erythema Gangrenosum, Detroit, Michigan, September 16-19, 1987. 24. 61st Annual Meeting, North Central Section, American Urological Association, DISCUSSANT/REVIEWER, Prostate, Detroit, Michigan, September 16-19, 1987. 25. 33rd Annual Meeting, American Paraplegia Society, E.S.W.L. in Quadriplegics - Can It Safely Be Performed Under Local Anesthesia? Las Vegas, Nevada, September 20-23, 1987. 26. Visiting Professor, Norwich Eaton Pharmaceuticals, Urinary Tract Infections, Norwich, New York, October 1-2, 1987. 27. Urology for the Non-urologist Postgraduate Course, Urethral Discharge, October 31, 1987. PRESENTATIONS (continued) 28. Urology for the Non-urologist Postgraduate Course, Initial Management of the Infertile Male, October 31, 1987. 29. Cuyahoga Community College lecture for Physician Assistant Students, Urinary Tract Infections, Cuyahoga Community College, Cleveland, February 8, 1988. 30. Case Western Reserve University School of Medicine, 2nd year class lecture, GU neoplasms, February 11, 1988. 31. Case Western Reserve University School of Medicine, Surgery Grand Rounds: Ureteral Injuries, February 13, 1988. 32. Geriatric City-Wide Grand Rounds: Urinary Incontinence in the Elderly, Cleveland Veterans Administration Medical Center, March 4, 1988. 33. Advances in the Management of Spinal Cord Injury, Case Western Reserve University School of Medicine Postgraduate Symposium. Treatment of Bladder-Sphincter Dyssynergia, March 18, 1988. 34. Advances in the Management of Spinal Cord Injury, Case Western Reserve University School of Medicine Postgraduate Symposium. Options for Impotence and Fertility in the SCI Male, Cleveland, Ohio, March 19,1988. 35. Advances in the Management of Spinal Cord Injury, Case Western Reserve University School of Medicine Postgraduate Symposium. Moderator for Urologic Section: Recent Advances in the Management of Urinary Stones in the SCI Patient and Autonomic Dysflexia - A New Look At An Old Problem, Cleveland, Ohio, March 19, 1988. 36. Visiting Professor, Norwich Eaton Pharmaceuticals, Antibiotic Usage in Urology, Norwich, New York, April 19-20, 1988. 37. Quest for Excellence in Spinal Cord Care and Practice, Case Western Reserve University School of Medicine Postgraduate Course, Management of Urologic Problems of the SCI Patient, Cleveland, Ohio, May 2, 1988, Cleveland. 38. Quest for Excellence in Spinal Cord Care and Practice, Case Western Reserve University School of Medicine Postgraduate Course, Sexual Options for SCI males, May 3, 1988. 39. Annual Meeting of International Medicine Society of Paraplegia, The Use of Verapamil in the Treatment of Detrusor Hyperreflexia, Perth, Western Australia, May 10-12, 1988. 40. Rehabilitative Medical Service Grand Rounds, "URINARY INCONTINENCE", VAMC, Cleveland, Ohio, June 27, 1988. 41. 34th Annual Meeting, American Paraplegia Society, Pharmacotherapy in Detrusor Hyperreflexia, Las Vegas, Nevada, September 6-9, 1988, PRESENTATIONS (continued) 42. 34th Annual Meeting, American Paraplegia Society, Poster: Psychosocial and Sexual Impact of SCI on the Male, Las Vegas, Nevada, September 6-9, 1988. 43. 62nd Annual Meeting, North Central Section, American Urological Association, The Effect of Verapamil on Detrusor Hyperreflexia, Orlando, Florida, November 13-19, 1988. 44. 62nd Annual Meeting, North Central Section, American Urological Association, Poster: Urologic Changes After Spinal Cord Compression in Dogs, Orlando, Florida, November 13-19, 1988. 45. 35th Annual Meeting, American Paraplegia Society, The Use of Verapamil in the Treatment of Autonomic Dysflexia, Las Vegas, Nevada, April 5-9, 1989. 46. 35th Annual Meeting, American Paraplegia Society, Moderator: Investigation Section. SCI Research, Las Vegas, Nevada, April 5-9, 1989. . 47. Annual Meeting of the International Medical Society of Paraplegia, Poster: The Use of Ultrasound in the Urological Management of the Spinal Cord Injured Patient, Rome, Italy, May 4-6, 1989. 48. 84th Annual Meeting, American Urological Association, The Use of Office ultrasound in the Spinal Cord Injured, Dallas, Texas, May 7-11, 1989. 49. CWRU School of Medicine Postgraduate. Course Entitled: "Female Urology" Talk Entitled: "Pharmacologic Management", Cleveland, Ohio, June 3, 1989. 50. Urinary Incontinence in the Elderly - Symposium sponsored by University Center on Aging and Health, CWRU School of Medicine; Evaluation and Assessment of Incontinence in the Elderly, Cleveland, Ohio, June 9, 1989. 51. Invited Speaker: American Association of Physically Handicapped: Sexual Options for the Disabled, Cleveland, Ohio, August 15, 1989. 52. 63rd Annual Meeting, North Central Section, American Urological Association, Urologist Performed Ultrasound in the Routine Follow-up of the SCI Patient, Chicaco, Illinois, September 20-23, 1989. 53. Spinal Cord Injury Symposium, (PVA, MARMEC, and Dayton VAMC), Dayton, Ohio: Sexual Functions and Dysfunctions: Options, October 23-24, 1989. 54. Medical Grand Rounds - Hough Norwood Clinic, Understanding urinary incontinence in the elderly, Cleveland, Ohio, November 8, 1989. 55. Visiting Professor, Department of Urology, Kyoto Prefectural University School of Medicine, Lecture: New Concepts in Urologic Management of Spinal Cord Injured Patients, Kyoto, Japan, March 2-6, 1990. PRESENTATIONS (continued) 56. 85th Annual Meeting, American Urological Association, Vasoconstrictive Devices vs. Injection Therapy: A Prospective Study for SCI patients, New Orleans, LA, May 13-17, 1990. 57. Annual Meeting of the International Medical Society of Paraplegia, The Role of Intracorporal Injection of Vasoactive Medications For Restoration of Erection in the SCI Male – A Three-Year Follow-up, Ramat Gan, Israel, June 4-7, 1990. 58. CWRU Postgraduate Education - Surgery Today: Impotence, Cleveland, Ohio, June 13, 1990. 59. CWRU Department of Surgery - Resident Reunion: Surgery for Impotence, Cleveland, Ohio, June 15, 1990. 60. 36th Annual Meeting, American Paraplegia Society, Moderator: Urologic Surgery, Las Vegas, Nevada, September 4-6, 1990. 61. CWRU School of Medicine, Postgraduate Course: Management of BPH and Prostatic Cancer. Lecture: Transurethral Resection of the Prostate. Cleveland, October 20, 1990. 62. CWRU School of Medicine, Postgraduate Course: Management of BPH and Prostatic Cancer. Lecture: Patient Assessment and Urodynamic Findings. Cleveland, October 20, 1990. 63. 40th Annual Meeting of the National Kidney Foundation, Inc., Invited Speaker: Impotency and Infertility in End Stage Renal Disease (Council on Urology Symposium): Non-Surgical Management of the Impotent Male, Washington, D.C., November 28 December 2, 1990. 64. Rehabilitative Grand Rounds MetroHealth Medical Center, Importance of Urologic Management after Spinal Cord Injury, Cleveland, Ohio, April 19, 1991. 65. New Concepts in Impotence. Lorain, Ohio, April 27, 1991. 66. CWRU Postgraduate Education: Surgery Today: New Concepts in Infertility, Cleveland, Ohio, May 1, 1991. 67. Annual Meeting of International Medical Society of Paraplegia, The Effect of Patient Compliance on Long-term Urologic Outcome of Spinal Cord Injury, Aylesburg, England, May 15-17, 1991. 68. CWRU Postgraduate Education: Director Urology Workshop. Update Clinical Skills, Course Director. Lecture: Incontinence - Evaluation and Management, Cleveland, Ohio, June 20-21, 1991. PRESENTATIONS (continued) 69. 37th Annual Meeting, American Paraplegia Society, Urologic Complications and Bladder Pressure in Patients with Spinal Cord Injury, Las Vegas, September 3-5, 1991. 70. 65th Annual Meeting, North Central Section American Urological Association, The Effect of Patient Compliance in Urologic Outcome in Spinal Cord Injury Patients, Scottsdale, Arizona, November 3-9, 1991. 71. 65th Annual Meeting, North Central Section, American Urological Association, Long-term Results with Injection Therapy in Erection in Patients with Spinal Cord Injury, Scottsdale, Arizona, November 3-9, 1991. 72. 65th Annual Meeting, North Central Section, American Urological Association, Video prostatectomy, Scottsdale, Arizona, November 3-9, 1991. 73. CWRU Postgraduate Education: SURGERY TODAY: Neurogenic Bladder -- New Approaches to Therapy, Cleveland, Ohio, December 11, 1991. 74. North Central Section, American Urological Association. Continuing Education Program, Pathophysiology of Incontinence, Cleveland, Ohio, September 24-27, 1992. 75. 66th Annual Meeting, North Central Section American Urological Association, Initial Experience with Anterior Sacral Root Stimulation for Bladder Emptying in SCI patients, Puerto Rico, October 25-31, 1992. 76. Annual meeting of International Medical Society of Paraplegia, Long-term Urologic Complications in SCI Patients, Ghent, Belgium, May 20, 1993. 77. Nursing Urology Workshop (International Urological Services), Incontinence and Interstitial Cystitis, Cleveland, Ohio, April 14-15, 1994. 78. Case Western Reserve University School of Medicine Continuing Education. Prostate Disease in the Elderly: An Update for Primary Care Physicians: Benign Prostatic Hypertrophy. Cleveland, Ohio - May 25, 1994. 79. Annual Meeting of International Medical Society of Paraplegia, TrimethoprimSulfamethoxazole prophylaxis against Urinary Tract Infection in the Chronic Spinal Cord Injury Patient. Stone Disease in SCI Patients By Crystal Analysis, Kobe, Japan, May 31 - June 2, 1994. 80. Visiting Professor, Spinal Cord Injury Unit. Tampa Department of Veteran Affairs Medical Center. Tampa, Florida - September 26-28, 1994. 81. 40th Annual Meeting American Paraplegia Society: Focus Session - Spinal Cord Injury Urology - "Newer Treatments of Bladder-Sphincter Dyssynergia." Las Vegas, Nevada September 5-9, 1994. 82. Medical Management of Benign Prostatic Hypertrophy - A look at the new alphablockers, CWRU Continuing Education. Cleveland, Ohio - June 21, 1995. PRESENTATIONS (continued) 83. Annual Meeting of International Medical Society of Paraplegia, Poster: Incidence and Etiologic Factors for Stone Formation in Spinal Cord Injury Patients, Nov. 1 - Nov. 4, 1995, New Delhi, India. 84. Annual Meeting of International Medical Society of Paraplegia, Invited APS State of Art Lecture: Pathophysiology of Autonomic Dysreflexia, Atlanta, Georgia, Aug. 18 - Aug. 20, 1996. 85. Annual Meeting North Central Section, American Urologic Association, Poster: United States Experience with the Brindley Anterior Sacral Root Stimulator for Bladder Management in Spinal Cord Injury Patients, Tucson, Arizona, Oct. 28 - Nov. 2, 1996. 86. Annual Meeting, American Urologic Association, Poster: United States Experience with the Brindley Anterior Sacral Root Stimulator for Bladder Management in Spinal Cord Injury Patients, New Orleans, Louisiana, April 12 - April 17, 1997. 87. Annual Meeting North Central Section, American Urologic Association, Poster: MUSE for Treatment of Erectile Dysfunction in SCI Male. Presentation: Posterior Sacral Rhizotomy for Treatment of Detrusor Hyperreflexia in SCI Patients, Monterey, California, September 22-27. 1997. 88. Evaluation and Management of Cancer for the Primary Practitioner - Prostate Cancer. CWRU Spring 1998, CME Conference, Cleveland, Ohio, March 14, 1998. 89. Symposium on functional electrical stimulation, (Pre Conference Symposium) 24th Annual meeting, American Spinal lnjury Association, Cleveland, Ohio April 19, 1998, Experience with Anterior Sacral Root Stimulation in SCI Patients. 90. 24th Annual Meeting, American Spinal Injury Association, 20 - 22, 1998 Instructional Course “Urologic Mangements of Individuals with Spinal Cord injury” Poster: Intraurethral alprostadil (MUSE) for treatment of erectile dysfuction in the SCI male, Cleveland, Ohio, April 20-22, 1998. 91. Moderator/Discussant: “EXPLORING OPPORTUNITIES TO RESTORE SEXUAL FUNCTION BY ELECTRICAL ACTIVATION OF THE NERVOUS SYSTEM. CWRU APPLIED NEURAL CONTROL RESEARCH DAY, Cleveland, Ohio, May 11 and 12, 1998. 92. Annual Meeting International Medical Society of Paraplegia, Iguzu Falls, Brazil, The role of Intraurethral Alprostadil for restoring erections in the SCI male, June 17-20, 1998. 93. Initial United States Experience with the Bradley Anterior Sacral Root Stimulator. Presented at The American Urological Association 93rd Annual Meeting. San Diego, CA, May 30-June 4, 1998. 94. Visiting Professor, Medical College of Ohio, June 2-3, 1999. PRESENTATIONS (continued) 95. Annual Meeting North Central Section AUA, Anterior Sacral Root Stimulation for Management of the Neurogenic Bladder in Spinal Cord Injury Patients, Chicago, Illinois, September 22-25, 1999. 96. 95th Annual Meeting AUA –Society for Urodynamics and Female Urology, Invited Speaker: Review of Anterior Sacral Root Stimulation in Spinal Cord Injury Patients, Atlanta, Georgia, April 28, 2000. 97. 96th Annual Meeting AUA- Plenary Session, Urinary Incontinence, Anaheim, CA, June 2-7, 2000. 98. 48th Annual Meeting-American Paraplegia Society, Symposium Director: Longterm Urologic Care of the Spinal Cord Injury/Disease Individual, Las Vegas, Nevada, September 2-5, 2002. 99. Annual Meeting North Central Section AUA, Surgical Access and Anatomy of the Puderval Nerve, Chicago, Illinois, September 18-21, 2002. 100. 50th Annual Meeting-American Paraplegia Society, Symposium Director: Sexual Function and Fertility in SCI, Las Vegas, Nevada, September 2004. 101. 51st Annual Meeting-American Paraplegia Society, Symposium Director: Update on Multiple Sclerosis, Las Vegas, Nevada, September 2006. 102. Invited Lecture: Pharmacology of the over active bladder. Annual Meeting North Central Section AUA, San Diego California, September, 16-18, 2006. 103. 52nd Annual Meeting-American Paraplegia Society, Symposium Director: Reproductive Technology and SCI an Update, Orlando, Florida, August, 2007. BIBLIOGRAPHY 1. Bodner DR, Lipuma JP and Resnick MI: Imagining Modalities: Basic principles and utilization of ultrasound in urologic malignancies. Principles and management of urologic cancer. Javadpour, N. (ed.), 2nd Edition, Williams & Wilkins Company. Baltimore, MD, 1983. 2. Bodner DR, Bryan PR, Lipuma JP and Resnick MI: Ultrasonograpy of the Urinary Bladder in Ultrasound in Urology. Resnick, MI and Sanders, RD, (eds.), 2nd Edition. Williams & Wilkins Company, Baltimore, MD, 1984. 3. Bodner DR, Kursh ED and Resnick MI: Palliative nephrostomy for relief of ureteral obstruction secondary to malignancy. Urology XXIV:8 (1984). 4. Bodner DR, Kursh ED and Resnick MI: Palliative nephrostomy for relief of ureteral obstruction secondary to malignancy. In: Yearbook of cancer. Yearbook Medical Publishers, Chicago, IL, 1985. 5. Bodner DR, Cohen JK and Resnick MI: Primary transitional cell carcinoma of the prostate. Journal D'Urologie, 91, Number 3:157-158, 1985. 6. Bodner DR: Impotence: Evaluation and treatment. In Spirnak JP (ed.): Primary Care. Clin. N. Am., Vol. 12, No. 4, 1985, 719-33. 7. Maksem JA, Suarez and Bodner DR: Fine needle aspiration biopsy of the prostate gland. Cystopathology: Vol. 13, No.4, 1985, 2-6. 8. Bodner DR, Lipuma JP and Resnick MI: Percutaneous drainage of the obstructed kidney. In: Re-operative surgery of the abdomen. Fry, DE, Editor, Marcel Dekkor, New York, 1986. 9. Hampel N, Bodner DR and Persky L: Ileal and jejeunal loops. Urol. Clin. N.Am., 13 (No.2):207-224, 1986. 10. Bodner DR, Cohen IK, Resnick MI: Primary Transitional Cell Carcinoma of the Prostate. J Urology (Paris) 1986; 92(2):121-2. 11. Bodner DR, Caldamone AA and Resnick MI: Acquired infundibular stenosis. Urology, 29: 19-21, 1987. 12. Bodner DR, Schultz CL and Resnick MI: Imaging techniques of the adrenal gland. In: Javadpour N. (ed.). Principles and management of adrenal cancer, London, SpringerVerlag, 1987, pp 69-82. 13. Bodner DR: Impotence. In Resnick MI and Kursh ED (eds): Urology: Problems in Primary Care. Medical Economics, Oradell, 1987, pp. 123-128. 14. Bodner DR: Abscess in and about the kidney. In Resnick, MI and Kursh, ED (eds.): Urology: Problems in primary care. Medical Economics, Oradell, 1987, pp. 113116. BIBLIOGRAPHY (continued) 15. Bodner DR: Urinary tract infections in men. In: Resnick MI and Kursh ED (eds.): Urology: Problems in Primary Care. Medical Economics, Oradell, 1987, pp. 107-112. 16. Bodner DR: Adrenal Tumors. In: Resnick MI and Kursh ED (Eds.): Urology: Problems in Primary Care. Medical Economics, Oradell, 1987, pp. 205-210. 17. Bodner DR: Male sexual dysfunction. In Resnick MI and Kursh, ED (eds.): Urology: Problems in Primary Care. Medical Economics, Oradell, 1987, pp.117-122. 18. Bodner DR: Urinary retention in the male. In: Resnick MI and Kursh ED (eds.): Urology: Problems in Primary Care. Oradell, 1987, pp. 311-316. 19. Bodner DR: Hydroceles in adults. In: Resnick MI and Kursh ED (eds.): Current Therapy in Genitourinary Surgery, Toronto, 1987. B.C. Decker, Inc. 20. Bodner DR, Hampel N, Maksem JA, Suarez M and Resnick MI: Aspiration biopsy of the prostate. World J. Urol., 5:62-64, 1987. 21. Bodner DR, Lindan R, Leffler E, Kursh ED and Resnick MI: The application of intracavernous injection of vasoactive medications in the spinal cord injured male. J. Urol., 138:310-311, 1987. 22. Lindan R, Leffler E and Bodner DR: Urologic management of the quadriplegic female. Paraplegia, Vol. 25 (5): 381-385, 1987. 23. Althof SE, Turner LA, Levin SB, Risen C, Kursh ED, Bodner DR, and Resnick MI: Intracavernosal injection in the treatment of impotence: A prospective study of sexual, physiological and marital functioning. Journal of Sexual Marital Therapy. Vol. 3, No. 3 155-167, 1987. 24. Bodner DR: Urologic management of the spinal cord injured patients. In: Resnick, MI (ed.): Current Trends in Urology. Vol. 4, Williams and Wilkins, 1988, pp. 29-42. 25. Spirnak JP, Bodner DR and Resnick MI: Extracorporal shock wave lithotripsy in traumatic quadriplegic patients: Can it safely be performed without anesthesia? J. Urol., 139:18, 1988. 26. Bodner DR: Urethral Syndrome. Urol. Clin. N. Am. Vol. 15, No. 4:699-704, 1988. 27. Kursh ED and Bodner DR: Alternative method to nerve sparing radial retropubic prostatectomy. Urology, Vol. 32, No. 3:205-209, 1988. 28. Bodner DR: Critical review of pharmacologic treatment of male infertility. Seminars in Reproductive Endocrinology. Vol. 6, No. 4:377-384., 1988. 29. Kursh ED, Bodner DR, Resnick MI, Althof, SE, Turner, L, Risen, C and Levine, S: Injection therapy for impotence. Urol. Clin. N. Am. Vol. 15, No. 4:625-629, 1988. BIBLIOGRAPHY (continued) 30. 31. Mortimer JT, Sweeney JD, Bodner DR and Ferguson AS: (Abstract) An implantable cuff electrode for collision block of pudendal nerve motor activity. Proc. 10th Annual Conf. of the IEEE - EMBS, pp. 1523-1524, 1988. 15, No. 4:625-629, 1988. Sweeney JD, Mortimer JT, Bodner DR and Ferguson AS: (Abstract) Collision Block of Motor Activity in Peripheral Nerve. Proc. of the World Congress on Medical Physics and Biomedical Engineering, Physics in Med. & Biol., Vol. 33, Suppl. 1, p. 162, 1988. 32. Bodner DR, Lindan R, Leffler E and Resnick MI: The effect of verapamil on the treatment of detrusor hyperreflexia, in the spinal cord injurd population. Paraplegia, 27:364-369, 1989. 33. Levine SB, Althof SE, Turner LA, Risen CB, Bodner DR, Kursh ED and Resnick MI: Side effects of self-administration of intracavernous papaverine and phentolamine for the treatment of impotence. J. Urol., 141:54-57, 1989. 34. Sweeney JD, Mortimer JT and Bodner DR: Acute Animal Studies on Electrically Induced Collision Block of Pudenal Nerve Motor Activity. Neurourol. and Urodynamics, 8:521-536, 1989. 35. Bodner DR: Sacral Root Electrical Stimulation of the Bladder. In: Resnick MI (ed.): Problems in Urology: Evaluation and Use of the New Technology in Urologic Surgery. Vol. 3, No. 3:386-394, 1989. 36. Levine SB, Althof SE, Turner LA, Kursh ED, Bodner DR, Resnick MI and Risen CB: Benefits and problems with intracavernosal injections for the treatment of impotence. Medical Aspects of Human Sexuality, 23:38-40, 1989. 37. Althof SE, Turner LA, Levine SB, Risen C, Kursh E, Bodner DR and Resnick MI: Why do so many people drop out from auto-injection therapy for impotence? J. Sex Marital Ther., 15:121, 1989. 38. Turner LA, Althof SE, Leuse SB, Risen CB, Bodner DR, Dursh ED, Resnick MI: Selfinjection of Papaverine and Phenotolamine in Treatment of Psychogenic Impotence. J. Sex Marital Ther. 15(3):163-7, 1989. 39. Bodner DR, Witcher M and Resnick MI: Application of Office Ultrasound in the management of the spinal cord injured patient. J. Urol., 143:969-972, 1990. 40. Bodner DR and Resnick MI: Complications of surgery for removal of renal and ureteral stone. In: Marshall, FF: Urological Complications, Medical and Surgical, Adult and Pediatric, 2nd Edition, St. Louis, Mosby Year Book, 1990, pp. 182-199. 41. Bodner DR: How Electrical Stimulation Improves Micturition. Contemporary Urology, November, 1990, pp. 39-45. 42. Turner LA, Althof SB, Levine SB, Tobias TR, Kursh ED, Bodner D and Resnick MI: Treating Erectile Dysfunction with External Vacuum Devices: Impact upon Sexual, Psychological and Marital Functioning. J. Urol., 144:79-82, 1990. BIBLIOGRAPHY (continued) 43. Sweeney JD, Mortimer JT and Bodner DR: Animal Study of Pudendal Nerve Cuff Electrode Implants for Collision Block of Motor Activity. Neurology and Urodynamics, 9:83-93, 1990. 44. Bodner DR, Delamater R, Bohlman H, Witcher M, Biro C and Resnick MI: Urologic changes after cauda equina compression in dogs. J. Urol., 143:186-190, 1990. 45. Bodner DR, Resnick MI: Complications of open renal stone surgery. In: Smith, RB and Ehrlich, RM (eds.): Complications of Urologic Surgery: Prevention and Management. Philadelphia, W.B. Saunders, 1990, pp. 160-172. 46. Bodner DR: Cushing's syndrome. In: Resnick MI and Nieh PT (eds): Case Studies in Urology for the House Officers. Baltimore, Williams and Wilkens, pp. 213-215, 1990. 47. Bodner DR: Urinary retention. In: Resnick MI and Nieh PT (eds): Case studies in urology for the house officers. Baltimore, Williams and Wilkens, pp. 173-175, 1990. 48. Delamarter RB, Bohlman HH, Bodner D and Biro C: Urologic Function After Experimental cauda Equina Compression. Cystometrograms Versus Cortical-Evoked Potentials. Spine, Vol. 15, No. 9:864-870, 1990. 49. Bodner DR, Resnick MI: Ultrasonograpy of the urinary bladder. In: Ultrasonography of the Urinary Tract, third edition. MI Resnick, MD Rifkin (eds), Williams and Wilkins, Baltimore, 1991, p 250. 50. Turner LA, Althof SE, Levine SB, Risen CBB, Bodner DR, Kursh ED and Resnick MI: Sexual, psychological and marital impact of self-injection of Papaverine and Phentolamine: A long-term prospective study. J. Sex & Marital Therapy 17:101-112, 1991. 51. Bodner DR and Resnick MI: Ultrasound of the Bladder. In: Resnick MI and Rifkin MD, Ultrasonography of the Urinary Tract. Vol. 3., Baltimore, Williams & Wilkins, pp. 250281, 1991. 52. Turner LA, Althof SB, Levine SB, Bodner DR, Kursh ED, Resnick MI: External Vacuum Devics in the Treatment of Erectile Dysfunction: A one year study of Sexual and Psychological mpact. J. Sex Martial Ther., 17(2): 81-93, 1991. 53. Pretlow TG, Pretlow TP, Yang B, Kaetzel CS, Delmoro CM, Kamis SM, Bodner DR, Kursh ED, Resnick MI and Bradley EL: Tissue concentrations of prostate specific antigen in prostate carcinoma and benign prostatic hyperplasia. Int. J. Cancer:49, 645649, 1991. 54. Bodner DR and Kursh ED: Vacuum constrictive devices. Current Opinion in Urol. 1(2):149, 1991. BIBLIOGRAPHY (continued) 55. Bodner DR: Endocrine Disorders and Impotence. In: Resnick MI and Kursh ED (eds): Current therapy in Genitourinary Surgery. (2nd Edition), B.C. Decker. St. Louis, 1992, pp. 545-546. 56. Bodner DR: Spermatocele. In: Resnick MI and Kursh ED (eds): Current Therapy in Genitourinary Surgery (2nd Edition), B.C. Decker, St. Louis, 1992, pp. 429-431. 57. Bodner DR, Resnick MI: Operations for renal stones. In: Mastery of Surgery-Urologic Surgery. JE Fowler, Jr., editor, Little Brown & Co., Boston, 1992, pp 52. 58. Bodner DR: Priapism. In: Resnick MI and Kursh ED (eds): Current Therapy in Genitourinary Surgery. B.C. Decker, St. Louis, pp. 429-431, 1992. 59. Turner LA, Althof SE, Levine SB, Bodner DR, Kursh ED, and Resnick MI: A 12-month comparison of the effectiveness of two treatments for erectile dysfunction: Self-injection versus external vacuum devices. Urology, February, 1992, Volume 39(2):139-44. 60. Althof SE, Turner LA, Levine SB, Bodner D, Kursh ED and Resnick MI: Through eyes of women: Sexual and psychological responses of women to their partner's treatment with self-injection or external vacuum therapy. J. Urol., 147:1024-1027, 1992. 61. Bodner DR, Leffler E and Frost F: The Role of Intracorporal Injection of Vasoactive Medications for Restoration of Erection in the SCI Male - A Three-Year Follow-up. Paraplegia, 30(2): 118-120, 1992. 62. Bodner DR and Resnick MI: Operations for Renal Stones. In: Fowler, JE, Jr. (ed.): Mastery of Surgery. Urologic Surgery, Boston, Little Brown and Company, 1992, pp. 52-61. 63. Bodner DR: Sexual Aspects and Rehabilitation in Spinal Cord Injury. In: Stoudemire, A and Fogel, BS (eds). Principles of Medical Psychiatry, Oxford University Press, 1993, pp 851-862 64. Smith EM, Bodner DR, Ruff RC, Hampel N and Resnick MI: Spinal cord compression secondary to prostate carcinoma: Treatment and prognosis. J. Urol, 149:330-333, 1993. 65. Pretlow TG, Wolman SR, Micale MA, Pelly RJ, Kursh ED, Resnick MI, Bodner DR, Jacobberger JW, Delmoro EM, et al: Xenografts of Primary Human Prostatic Carcinoma. J Nat’l. Cancer Inst. 85(5): 394-8, 1993. 66. Shingleton WB and Bodner DR: The development of urologic complications in relationship to bladder pressures in spinal cord injury patients -- Journal of the American Paraplegia Society, 16 (1): 14 -17, 1993. 67. Smith EM and Bodner DR: Sexual Dysfunction After Spinal Cord Injury. In: Bodner, DR (ed): Urologic Clinics of North America, Vol. 20, 1993: pp. 535-542. BIBLIOGRAPHY (continued) 68. Bodner, DR (ed.): Urologic Clinics of North America: Spinal Cord Injury, Vol. 20 (3), 1993. 69. Wainstein MA, He F, Robinson D, Kung HJ, Schwartz S, Giaconia JM, Edgehouse NL, Prtlow TP, Bodner DR, Kursh ED, et al.: Androgen-Dependent Xenograft Model Derived from a Primary Human Prostatic Carcinoma. Cancer Res. 1994 Dec. 1:54(23): 6049-52. 70. Creasey GH, and Bodner DR: A Review and Current Concepts of Sacral Stimulation, Journal Neurorehabilitation, 1995. 71. Bodner DR: Neurogenic Bladder, In: Urology Secrets. Resnick MI & Novick AC (ed.) Philadelphia, Hanley & Belfus, Inc., 44-46, 1995. 72. Bodner DR: Radionuclide Studies, In: Urology Secrets. Resnick MI & Novick AC (ed.) Philadelphia, Hanley & Belfus, Inc., 20-21, 1995. 73. Bodner DR: Scrotal Abscess. In: Urology Secrets. Resnick MI & Novick AC (ed.) Philadelphia, Hanley, & Belfus, Inc., 215-216, 1995. 74. Sandock DS, Gothe BG, and Bodner DR: Trimethoprim-Sulfamethaxazole Prophylaxis Against Urinary Tract Infection in the Chronic Spinal Cord Injury Patient. Paraplegia: 33, 156-160, 1995. 75. Bodner DR, Selzman AA, and Spirnak JP: Evaluation and Treatment of Bladder Rupture. Seminars in Urology. Vol. 8 (No. 1), 62-65, 1995. 76. Carlin BI, Bodner DR, Spirnak JP, and Resnick MI: Role of Finasteride in the Treatment of Recurrent Hematuria Secondary to Benign Prostatic Hyperplasia. Prostate 31:3 (May 15, 1997), 180-182. 77. Seftel AD, Reigle M, Bodner DR: Neurorehabilitation and Sexual Function After Spinal Cord Injury. In: Lazar, RB (ed): Principles of Neurologic Rehabilitation, New York, McGraw Hill, 1998, Chapter 25, p. 433-444. 78. Haas CA, Bodner DR, Hampel N. and Resnick MI: Systemic candidiasis Presenting with Prostatic Abscess. Br J Urol, 82(3): 450-451, 1998. 79. Brown SL, Haas CA, Koehler M, Bodner DR and Seftel AD: Hepatotoxicity related to Intracavernous pharmacoltherapy with papaverine. Urology, 52:844-847, 1998. 80. Perkash I, Linsenmeyer TA, Bodner DR, Anderson RU: Detrusor-sphincter dyssynergia and vesico urethral reflux: management. Spinal Cord. 1998 Jan; 36(1):2-5. 81. Bodner DR: Urologic Management of Acute Spinal Cord Injury. AUA News -1999 82. Bodner DR, Haas CA, Krueger B, Seftel AD: Intraurethral Alprostadil for Treatment of Erectile Dysfunction in Spinal Cord Injury Patients. Urology - 53(1): 199-202, 1999. BIBLIOGRAPHY (continued) 83. Bodner DR, Greenberg DB, Seftel AD: Sexual Aspects and Rehabilitation in Spinal Cord Injury. In: Stoudemire A and Fogel BS (eds): Psychiatric Care of the Medical Patient 2nd Edition, Oxford University Press, New York 1000, pp. 1081-94. 84. Bodner DR and Levy: Radionuclide Studies, In: Resnick MI and Novick AC, (eds): Urology Secrets Second Edition. Philadelphia. Hanley and Belfus, Inc. 1999, p22-23. 85. Bodner DR: Neurogenic bladder. In Resnick MI and Novick AC (eds): Urology Secrets Second Edition. Philadelphia. Hanley and Belfus, Inc. 1999, p50-51 86. Bodner DR: Scrotal Abscess. In Resnick MI and Novick AC (eds): Urology Secrets Second Edition. Philadelphia. Hanley and Belfus, Inc. 1999, p246-247 87 Oefelein MG, Ricchuiti V, Conrad W, Seftel A, Bodner D, Goldman H, Resnick M: Skeletal fracture associatd with androgen suppression induced osteoporosis: the clinical incidence and risk factors for patients with prostate cancer. J Urol. 2001. Nov. 166(5): 1724-8. 88. Bodner DR, McKenna KE, Sipski ML. Restoring sexual function by electrical activation of the nervous system: a symposium. J Spinal Cord Med. 2001 Fall; 24(3):147. 89. Oefelein MG, Ricchuiti V, Conrad W, Goldman H, Bodner D, Resnick MI, Seftel A: Clinical predictors of androgen-independent prostate cancer and survival in the prostatespecific antigen ERA. Urology 60(1): 120-124,2002. 90. Bodner DR and Perkash I: Urologic Management in Spinal Cord Injury. In: Lin VW (ed) Bod: Spinal Cord Medicine Principles and Practice-New York, Demos, pp. 299-305, 2003. 91. Bodner DR: Radionuclide Studies, In: Resnick MI and Novick AC (eds.) Urologic Secrets-Third Edition-Philadelphia, Hanley and Belfus, Inc-2005 92. Bodner DR: Neurogenic Bladder, In: Resnick and Novick AC (eds): Urology Secrets Third Edition-Philadelphia, Hanley and Belfus, Inc. 2005 93. Bodner DR: Scrotal Abscess. In Resnick MI and Novick AC (eds) Urology Secrets Third Edition – Philadelphia, Hanley and Belfus, Inc. 2005 94. Fleshman RL, Wasman JK, Bodner DR, Young RH, MacLennan GT> Mesodermal adenosarcoma of the testis. Am J Surg Pathol. 2005 Mar;29(3):420-23. 95. Gustafson KJ, Zelkovic PF, Feng AH, Daper CE, Bodner DR, Grill WM: Fascicular anatomy and surgical access of the human pudendal nerve. World J Urol. 2005 Dec;23(6):411-9. 96. Bodner DR: Septic Shock. In: Resnick MI, Elder JS & Spirnak JP (eds): Critical Decisions in Urology, 3rd Edition. Hamilton London. BC Decker, Inc. 2004, p84-85. BIBLIOGRAPHY (continued) 97. Vourganti S, Agarwal PK. Bodner DR, Dogra VS. Ultrasonographic Evaluation of Renal Infections: Radiol Clin North Am 2006 Nov;44(6):763-75. 98. Consortium for Spinal Cord Medicine. Bladder Management for Adults with Spinal Cord Injury. A clinical practice guideline for healthcare providers. JSCM. 2006; 29: pg 527573 99. Bodner DR: Peer review of scientific papers. JSCM. 2006;29(2):91. 100. Sipski M, Alexander M, Bodner D, Brackett N, Elliot S, Jackson AB, Sonksen J: Development of International Standards to document to sexual and reproductive function after spinal cord injury: preliminary report JRRD: 2007;44:1:83-90 101. Ellis RJ, Zhou EH, Fu P, Kaminsky DA, Sodee DB, Faulhaber PF, Bodner D, Resnick MI. Single photon emission eomputerized tomography with capromab pendetide plus computerized tomography image set co-registration independently predicts biochemical failure. J Urol. 2008 May; 179(5):1768-73. 102. Zhou EH, Ellis RJ, Cherullo E, Colussi V, Xu F, Chen WD, Gupta S, Whalen CC, Bodner D, Resnick MI, Rimm AA, Koroukian SM. Radiotherapy and survival in prostate cancer patients: a population-based study. Int J Radiat Oncol Biol Phys. 2009 Jan 1; 73(1): 15-23. 103. Alexander MS, Biering_Sorensen F, Bodner D, Brackett NL, Cardenas D, Charlifue S, Creasey G, Dietz V, Ditunno J, Donovan W, Elliott SL, Estores I, Graves DE, Green B, Gousse A, Jackson AB, Kennelly M, Karlsson AK, Krassioukov A, Krogh K, Linsenmeyer T, Marino R, Mathias CJ, Perkash I, Sheel AW, Schilero G, Schurch B, Sonksen J, Stiens S, Wecht J, Wuermser LA, Wyndaele JJ. International standards to document remaining autonomic function after spinal cord injury. Spinal Cord. 2009 Jan; 47(1):36-43. 104. Bodner DR: Veteran’s day reflections. J Spinal Cord Med. 2008; 31(5)485. 105. Vykhovanets EV, Shukla S, MacLennan GT, Vykovanets OV, Bodner DR, Gupta S. 11-1 beta-induced post-transition effect of NF-kappaB provides time-dependent wave of signals for initial phase of intraprostatic inflammation. Prostate. 2009 May 1; 69(6):633-43. 106. Bodner DR: The Bors Award: legacy of Ernest H. J. “Pappy” Bors, MD. J Spinal Cord Med. 2009;32(1): 1-2. 107. Bodner DR: Expanding the options of spinal cord injury research. J Spinal Cord Med. 2009. 32(2):103 108. Bodner DR: A pioneer in optimism: the legacy of Donald Munro, MD. J Spinal Cord Med. 2009. 32(4):355-6. 109. Bodner DR: The Comarr Memorial Award for Distinguished Clinical Service: the legacy of A. Estin Comarr, MD. J Spinal Cord Med. 2009; 32(3):213-4. 110. Alexander MS, Brackett NL, Bodner D, Elliott S, Jackson A, Sonksen J. Measurement of sexual functioning after spinal cord injury: preferred instruments. J Spinal Cord Med. 2009;32(3):226-36. 111. Singh M, Perkash and Bodner DR: Urologic Management in Spinal Cord Injury. In: Lin W (ed) Spinal Cord Medicine Principles and Practice Second Edition-New York DemosIn Press
© Copyright 2024